Kadimastem is a regenerative medicine company focused on the industrial development and commercialization of stem cell-based therapeutics, primarily for diabetes and neurodegenerative disorders. The company’s proprietary technologies and know-how enable the differentiation of stem cells into insulin secreting beta cells as well as a range of neural cells, including Oligodendrocytes and Astrocytes. Based on its differentiation technologies, the company advances two therapeutic programs focused on diabetes mellitus and ALS, where stem cells are differentiated into beta cells for the diabetes program and astrocytes are differentiated into beta cells for the ALS program, with the goal of implanting them into patients, and affecting diseases progression. The company’s technology is designed to screen compounds automatically and quantify the readouts using a cell-based High Content Screening (HCS) system. Kadimastem partners with pharmaceutical companies to screen potential drug compounds on its stem-cell derived cells. It produces a number of human cell and tissue systems that constitute screening platforms to search for agonists or antagonists of specific biological processes, with the aim of developing safe drugs. Kadimastem is based in Nes Ziona, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
11
Frequently Asked Questions
What is Market Cap of Kadimastem Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kadimastem Ltd. market cap is $29.17M.
What is the 52-week high for Kadimastem Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kadimastem Ltd. 52 week high is $5.10 as of November 21, 2025.
What is the 52-week low for Kadimastem Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kadimastem Ltd. 52 week low is $0.6404 as of November 21, 2025.
What is Kadimastem Ltd. stock price today?
Kadimastem Ltd. stock price today is $5.06.
What was Kadimastem Ltd. stock price yesterday?
Kadimastem Ltd. stock price yesterday was $5.10.
What is the PE ratio of Kadimastem Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kadimastem Ltd.’s P/E ratio is -1.30.
What is the Price-to-Book ratio of Kadimastem Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kadimastem Ltd. P/B ratio is -1.5111.
What is the 50-day moving average of Kadimastem Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kadimastem Ltd. 50-day moving average is $5.06.